Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 2/2014

01-03-2014 | Author's Reply

In reply: Maspin and it’s evolving role in tumor progression in systemic malignancies

Authors: Asru K. Sinha, Rajeshwary Ghosh

Published in: Breast Cancer | Issue 2/2014

Login to get access

Excerpt

In reference to the letter by Dr. Kapoor [1], the author elegantly described the role of maspin synthesis in the possible contribution both in bladder and colorectal cancer. In the letter, the author claimed that the expression of maspin (gene) indicated a worst prognostic outcome in bladder and colorectal cancer. …
Literature
1.
2.
Ganguly Bhattacharjee K, Bhattacharyya M, Halder UC, Jana P, Sinha AK. The role of neutrophil estrogen receptor status on maspin synthesis via nitric oxide production in human breast cancer. J Breast Cancer. 2012;15(2):181–8.PubMedCentralPubMedCrossRef
3.
Bhattacharjee KG, Bhattacharyya M, Halder UC, Jana P, Sinha AK. The “Cross Talk” between the receptors of insulin, estrogen and progesterone in neutrophils in the synthesis of maspin through nitric oxide in breast cancer. Int J Biomed Sci. 2012;8(2):129–39.PubMed
4.
Girish GV, Sinha N, Chakraborty K, Bhattacharya G, Kahn NN, Sinha AK. Restoration by aspirin of impaired plasma maspin level in human breast cancer. Acta Oncol. 2006;45(2):184–7.PubMedCrossRef
Metadata
Title
In reply: Maspin and it’s evolving role in tumor progression in systemic malignancies
Authors
Asru K. Sinha
Rajeshwary Ghosh
Publication date
01-03-2014
Publisher
Springer Japan
Published in
Breast Cancer / Issue 2/2014
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-013-0510-2

Other articles of this Issue 2/2014

Breast Cancer 2/2014 Go to the issue

Original Article

Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone

Original Article

Anxiety, depression, and quality of life in German ambulatory breast cancer patients

Original Article

Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life 2 years after breast cancer surgery

Original Article

Breast biopsy for mammographically detected nonpalpable lesions using a vacuum-assisted biopsy device (Mammotome) and upright-type stereotactic mammography unit without a digital imaging system: experience of 500 biopsies

Original Article

Underestimation of papillary breast lesions by core biopsy: correlation to surgical excision

Original Article

Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits